Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism

Clinical Parkinsonism & Related Disorders · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles